PROMIS NEUROSCIENCES INC. Proceeds from Issuance of Warrants
PROMIS NEUROSCIENCES INC. (PMN) reported Proceeds from Issuance of Warrants of $1.52 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2024-04-01
- PROMIS NEUROSCIENCES INC. proceeds from issuance of warrants for the quarter ending 2021-12-31 was $0.00.
- PROMIS NEUROSCIENCES INC. proceeds from issuance of warrants for fiscal 2022 was $1.52M, a 44.50% decline from fiscal 2021.
- PROMIS NEUROSCIENCES INC. proceeds from issuance of warrants for fiscal 2021 was $2.74M.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|
| 2022-12-31 | $1.52M 10-K · filed 2024-04-01 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $2.74M 10-K · filed 2023-03-08 | |
| 2021-09-30 | $2.74M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |